Live search
TopFind is fetching the latest matches for your search.
We reviewed 4 live results for idacio and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biologics and Rheumatology.
Sumber: Fresenius Kabi (Singapore) Pte Ltd
Deskripsi
Idacio is an adalimumab biosimilar registered in Singapore since 2021. It is available as a solution for injection in various formats including pre-filled pens, syringes, and vials (40mg/0.8ml). It is used for the treatment of immune-mediated inflammatory diseases.
Paling cocok untuk
vial-based administration, pen-based injection and HSA-registered treatments
Penilaian
Sumber: Fresenius Kabi Philippines, Inc.
Deskripsi
Idacio is a citrate-free adalimumab biosimilar biologic medicine manufactured by Fresenius Kabi. Delivered as a 40 mg/0.8 mL solution for subcutaneous injection, it is available in prefilled pen (auto-injector) and prefilled syringe formats. It is indicated for treating chronic inflammatory conditions such as Rheumatoid Arthritis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis, providing a highly similar alternative to the reference product Humira.
Paling cocok untuk
rheumatoid arthritis treatment, inflammatory bowel disease therapy, citrate-free injection preference and adalimumab biosimilar therapy
Penilaian
Sumber: Fresenius Kabi
Deskripsi
Idacio is a biosimilar biologic medication containing adalimumab, a TNF-alpha inhibitor used to treat a wide range of inflammatory conditions. These include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. The medication is typically provided as a 40 mg/0.8 mL solution for subcutaneous injection, available in formats such as a single-dose pre-filled pen (autoinjector), a pre-filled syringe, or a single-dose vial for pediatric or specific dosing needs. As a biosimilar, it offers a clinically equivalent and often more accessible alternative to the reference product Humira.
Paling cocok untuk
rheumatoid arthritis treatment, psoriasis management, Crohn’s disease patients, biosimilar medication seekers and subcutaneous injection therapy
Penilaian
| Bandingkan | Idacio | Idacio (Adalimumab) | Idacio (adalimumab) |
|---|---|---|---|
| Sumber | Fresenius Kabi (Singapore) Pte Ltd | Fresenius Kabi Philippines, Inc. | Fresenius Kabi |
| Deskripsi | Idacio is an adalimumab biosimilar registered in Singapore since 2021. It is available as a solution for injection in various formats including pre-filled pens, syringes, and vials (40mg/0.8ml). It is used for the treatment of immune-mediated inflammatory diseases. | Idacio is a citrate-free adalimumab biosimilar biologic medicine manufactured by Fresenius Kabi. Delivered as a 40 mg/0.8 mL solution for subcutaneous injection, it is available in prefilled pen (auto-injector) and prefilled syringe formats. It is indicated for treating chronic inflammatory conditions such as Rheumatoid Arthritis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis, providing a highly similar alternative to the reference product Humira. | Idacio is a biosimilar biologic medication containing adalimumab, a TNF-alpha inhibitor used to treat a wide range of inflammatory conditions. These include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. The medication is typically provided as a 40 mg/0.8 mL solution for subcutaneous injection, available in formats such as a single-dose pre-filled pen (autoinjector), a pre-filled syringe, or a single-dose vial for pediatric or specific dosing needs. As a biosimilar, it offers a clinically equivalent and often more accessible alternative to the reference product Humira. |
| Paling cocok untuk | vial-based administration, pen-based injection and HSA-registered treatments | rheumatoid arthritis treatment, inflammatory bowel disease therapy, citrate-free injection preference and adalimumab biosimilar therapy | rheumatoid arthritis treatment, psoriasis management, Crohn’s disease patients, biosimilar medication seekers and subcutaneous injection therapy |
| Tag | |||
| Aksi | Lihat detail | Lihat detail | Lihat detail |
| Penilaian |
Jika Anda ingin memulai dari opsi yang paling seimbang, saya merekomendasikan:
"Idacio from Fresenius Kabi (Singapore) Pte Ltd."
Saya memilih ini karena One of the few biosimilar options that includes a vial format for specific clinical needs.